TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Svea Vaccin AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
85,328
|
134,859
|
113,033 |
| Financial expenses |
72
|
38
|
0 |
| Earnings before taxes |
-16,175
|
11,120
|
12,529 |
| EBITDA |
-15,505
|
11,277
|
12,050 |
| Total assets |
14,845
|
31,050
|
24,900 |
| Current assets |
10,521
|
28,771
|
22,699 |
| Current liabilities |
11,988
|
18,083
|
13,875 |
| Equity capital |
2,857
|
11,785
|
10,364 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
94
|
91
|
65 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
19.2%
|
38.0%
|
41.6% |
| Turnover per employee |
908
|
1,482
|
1,739 |
| Profit as a percentage of turnover |
-19.0%
|
8.2%
|
11.1% |
| Return on assets (ROA) |
-108.5%
|
35.9%
|
50.3% |
| Current ratio |
87.8%
|
159.1%
|
163.6% |
| Return on equity (ROE) |
-566.2%
|
94.4%
|
120.9% |
| Change turnover |
-45,070
|
21,244
|
-43,245 |
| Change turnover % |
-35%
|
19%
|
-28% |
| Chg. No. of employees |
3
|
26
|
-15 |
| Chg. No. of employees % |
3%
|
40%
|
-19% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.